By -
Recap of visit with Rep. Charles Dent (R-15 PA) by Jenessa Smith


Charles Dent (R)
15th District PA Congressman

The meeting with Representative Dent’s staffer Lauren Kent –Stevens went very well. She was receptive to our messages of urging Rep. Dent to continue his commitment to prioritizing the NIH. She reiterated that Rep. Dent is a member of the appropriation committee that allocates funding for agencies such as the NIH and that although he cannot sign HR1301 to send to himself, he would respond favorably to the measure once it reaches his committee. In addition, Ms. Kent informed us that Rep. Dent co-chairs the House ethics committee, which informs a bipartisan group of representatives about novel and exciting research by inviting scientists and innovators to speak at meetings. Ms. Kent was interested in our research and about the grant finding and application process. Finally, Ms. Kent urged us to reach out to state legislators that do not see the importance of NIH funding in their states, simply because they may not receive NIH funding to institutions or companies in their respective states or districts. She wanted us to inform people that NIH funding has provided us with many life-saving treatments and techniques that would not be available today with support from the NIH. In all, it was a productive meeting and we left our message to reverse the sequester-enforced NIH budget cuts and that NIH budget must increase in the future.    

Comments

  1. Penn Science PolicyApril 9, 2013 at 4:42 PM

    Turns out Rep. Charles Dent turned up at Penn a day after our visit!

    ReplyDelete

Post a Comment

Popular posts from this blog

2015 AAAS Science and Technology Policy Forum Summary

By -
I recently had the opportunity to attend the 2015 AAAS Science and Technology Policy Forum in Washington, D.C. This annual meeting brings together a range of academics and professionals to discuss the broad S&T policy landscape. Below are some of my takeaways from the meeting. I hope to have additional comments from other National Science Policy Group members up soon. By Chris Yarosh The talks and panels at the Forum encompassed a huge range of topics from the federal budget and the appropriations outlook to manufacturing policy and, of course, shrimp treadmills . My opinion of the uniting themes tying this gamut together is just that—my opinion— and should only be taken as such. That being said, the threads I picked on in many of the talks can be summarized by three C’s: cooperation, communication, and citizenship . First up, cooperation. Although sequestration’s most jarring impacts have faded, AAAS’s budget guru Matthew Hourihan warns that fiscal year 2016 could ...
Read more

AAAS Forum Take #2

By -
Another point of view of the AAAS Forum by Matthew Facciani: I have provided scientific testimony and met with some of my local legislators, but I’ve never had any formal exposure to science policy. I was really excited to hear about the AAAS Science & Technology Policy Forum to learn more about how scientists can impact policy. The information I absorbed at the conference was overwhelming, but incredibly stimulating. Some of the lectures discussed the budget cuts and the depressing barriers for achieving science policy. However, I felt there was definitely an atmosphere of optimism at the conference and it was focused on how we can create positive change. One of my favorite aspects of the conference were the discussions of how to effectively communicate science to non-scientists. Before we can even have discussions of funding, the general public needs to understand how science works and why basic science is so important. For example, science never proves anything with 100%...
Read more

Dr. Sarah Cavanaugh discusses biomedical research in her talk, "Homo sapiens: the ideal animal model"

By -
Image
Biology and preclinical medicine rely heavily upon research in animal models such as rodents, dogs, and chimps. But how translatable are the findings from these animal models to humans? And what alternative systems are being developed to provide more applicable results while reducing the number of research animals? Image courtesy of PCRM Last Thursday, PSPG invited Dr. Sarah Cavanaugh from the Physicians Committee for Responsible Medicine to discuss these issues. In her talk entitled, “ Homo sapiens : the ideal animal model,” she emphasized that we are not particularly good at translating results from animal models into human patients. Data from the FDA says that 90% of drugs that perform well in animal studies fail when tested in clinical trials.  It may seem obvious, but it is important to point out that the biology of mice is not identical to human biology. Scientific publications have demonstrated important dissimilarities in regards to the pathology of inflammation...
Read more